ADVANZ PHARMA Corp.

ADVANZ PHARMA is a global pharmaceutical company determined to deliver sustainable value across our portfolio of products in the global specialty off patent sector.



Contact Information
Adam Peeler 
Tel: 905-842-5150 x 240
[email protected]

Latest

Nov 18, 2021, 02:00 ET ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth

Dr. Steffen Wagner appointed as new Chief Executive Officer and Andreas Stickler as new Chief Financial Officer LONDON, Nov. 18, 2021 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the...

Jun 01, 2021, 05:13 ET Nordic Capital Acquires Specialty Pharmaceutical Company ADVANZ PHARMA in Deal Worth ~$846 Million

The acquisition will bring significant investment and expertise to help fuel ADVANZ PHARMA's growth, with the potential to bring further cost-savings to the NHS and wider European healthcare systems...

May 14, 2021, 07:00 ET ADVANZ PHARMA Corp. Limited Announces First Quarter 2021 Results

First quarter 2021 revenue of $136 million First quarter 2021 net loss of $15 million First quarter 2021 Adjusted EBITDA1 of $56 million Generated cash flow from operations of $13 million and...

Mar 17, 2021, 07:00 ET ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2020 Results

2020 revenue of $526 million and fourth quarter 2020 revenue of $135 million 2020 net loss of $75 million and fourth quarter net income of $2.4 million 2020 Adjusted EBITDA1 of $233 million and...

Jan 27, 2021, 03:25 ET ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic Capital

LONDON, Jan. 27, 2021 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), a specialty pharmaceutical company with a strategic focus on complex medicines in Europe, today announced ...

Nov 06, 2020, 07:00 ET ADVANZ PHARMA Corp. Limited Announces Third Quarter 2020 Results

Third quarter 2020 revenue of $129 million Third quarter 2020 net loss of $42 million Third quarter 2020 Adjusted EBITDA1 of $53 million Generated cash flow from operations of $113 million in the...

Oct 23, 2020, 07:00 ET ADVANZ PHARMA Corp. Limited Announces Release Date for Third Quarter 2020 Results

LONDON, Oct. 23, 2020 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), an international specialty pharmaceutical company focused on serving the needs of patients and healthcare ...

Aug 12, 2020, 07:00 ET ADVANZ PHARMA Corp. Limited Announces Second Quarter 2020 Results

Second quarter 2020 revenue of $132 million Second quarter net loss of $27 million Second quarter 2020 Adjusted EBITDA1 of $65 million Generated cash flow from operations of $107 million in the first ...

Jul 29, 2020, 17:00 ET ADVANZ PHARMA Corp. Limited Announces Release Date for Second Quarter 2020 Results

LONDON, July 29, 2020 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), an international specialty pharmaceutical company focused on serving the needs of patients and healthcare ...

Jun 17, 2020, 16:00 ET ADVANZ PHARMA Corp. Limited Announces Results of Annual Meeting of Shareholders

LONDON, England, June 17, 2020 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), a global pharmaceutical company focused on serving the needs of patients and healthcare...

Jun 15, 2020, 07:00 ET Correvio Provides Update Pursuant to BCI 51-515 - Temporary Exemption from Certain Corporate Finance Requirements

VANCOUVER, BC, June 15, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") is providing an update on material business developments of the Company in accordance with Section 10(2) of...

May 27, 2020, 11:42 ET ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.

Provides ADVANZ PHARMA with an immediate and direct commercial and medical presence in Germany, France, Spain, Italy, and the Benelux region, while strengthening its existing presence in the Nordics...

May 13, 2020, 07:00 ET ADVANZ PHARMA Corp. Limited Announces First Quarter 2020 Results

First quarter 2020 revenue of $130 million First quarter net loss of $9 million First quarter 2020 Adjusted EBITDA1 of $63 million Generated cash flow from operations of $45 million in 2020 and...

Apr 29, 2020, 07:00 ET ADVANZ PHARMA Corp. Limited Announces Release Date for First Quarter 2020 Results

LONDON , April 29, 2020 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), an international specialty pharmaceutical company focused on serving the needs of patients and...

Apr 01, 2020, 17:39 ET ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million

LONDON, April 1, 2020 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around...

Mar 27, 2020, 17:00 ET ADVANZ PHARMA Corp. Limited Completes Voluntarily Delisting from the Toronto Stock Exchange

LONDON, March 27, 2020 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around ...

Mar 25, 2020, 07:00 ET ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2019 Results

2019 revenue of $508 million, fourth quarter 2019 revenue of $122 million 2019 net loss of $196 million and fourth quarter net loss of $25 million 2019 Adjusted EBITDA1 of $234 million and fourth...

Mar 16, 2020, 07:00 ET ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.

Provides ADVANZ PHARMA with an immediate and direct commercial presence in Germany, France, Spain, Italy, and the Benelux region, while strengthening its existing presence in the Nordics and the...

Mar 11, 2020, 17:00 ET ADVANZ PHARMA Corp. Limited Announces Release Date for Fourth Quarter and 2019 Results

LONDON, March 11, 2020 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on serving the needs of patients...

Mar 10, 2020, 07:00 ET ADVANZ PHARMA Corp. Limited to Voluntarily Delist from the Toronto Stock Exchange

LONDON, March 10, 2020 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company") (TSX: ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare...

Mar 06, 2020, 07:00 ET ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million

LONDON, March 6, 2020 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare...

Feb 12, 2020, 07:00 ET ADVANZ PHARMA Corp. Limited Comments on CMA Supplemental Statement of Objections Related to Hydrocortisone Tablets

LONDON, Feb. 12, 2020 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company") (TSX: ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare...

Jan 08, 2020, 17:00 ET ADVANZ PHARMA Announces Changes to its Board of Directors and Completion of its Continuance to Western Europe

LONDON, Jan. 8, 2020 /CNW/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company") (TSX: ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare...

Dec 17, 2019, 17:00 ET ADVANZ PHARMA Corp. Announces Results of Special Meeting of Shareholders

TORONTO, Dec. 17, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX: ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare providers...

Nov 27, 2019, 07:00 ET ADVANZ PHARMA Corp. Announces Proposal to Re-domicile from Canada to Europe

TORONTO, Nov. 27, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on serving the needs of patients and...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE